Alector Inc Share Price Today: Live Updates & Key Insights

Alector Inc share price today is $2.05, up -0.49%. The stock opened at $2.03 against the previous close of $2.06, with an intraday high of $2.09 and low of $2.005.

Alector Inc Share Price Chart

Alector Inc

us-stock
To Invest in {{usstockname}}
us-stock

Alector Inc Share Price Performance

$2.05 -0.0049(-0.49%) ALEC at 23 Mar 2026 11:57 AM Biotechnology
Lowest Today 2.005
Highest Today 2.09
Today’s Open 2.03
Prev. Close 2.06
52 Week High 3.40
52 Week Low 0.87
Day’s Range: Low 2.005 High 2.09
52-Week Range: Low 0.87 High 3.40
1 day return -
1 Week return -7.04
1 month return -2.38
3 month return +40.54
6 month return -35.59
1 year return +49.81
3 year return -65.1
5 year return -90.82
10 year return -

Alector Inc Institutional Holdings

BlackRock Inc 6.52

Vanguard Group Inc 6.26

Foresite Capital Management IV, LLC 3.52

Merck & Co Inc 3.21

683 Capital Management LLC 3.04

Balyasny Asset Management LLC 2.96

Vanguard Total Stock Mkt Idx Inv 2.30

Acadian Asset Management LLC 2.15

D. E. Shaw & Co LP 2.14

FMR Inc 2.02

Fidelity Select Biotechnology 2.01

T. Rowe Price Associates, Inc. 1.98

Jacobs Levy Equity Management, Inc. 1.97

Geode Capital Management, LLC 1.88

Kynam Capital Management, LP 1.81

iShares Russell 2000 ETF 1.73

State Street Corp 1.57

Renaissance Technologies Corp 1.40

Medici Capital LLC 1.36

Eversept Partners, LP 1.35

Millennium Management LLC 1.21

Euclidean Capital LLC 1.19

Marshall Wace Asset Management Ltd 1.06

Vanguard Institutional Extnd Mkt Idx Tr 0.94

Fidelity Small Cap Index 0.72

Vanguard VIF Small Co Gr 0.64

BlackRock Advantage Small Cap Core Instl 0.58

Vanguard Strategic Small-Cap Equity Inv 0.57

iShares Russell 2000 Value ETF 0.57

Vanguard Explorer Inv 0.54

State St Russell Sm/Mid Cp® Indx SL Cl I 0.47

Fidelity Extended Market Index 0.45

Schwab US Small-Cap ETF™ 0.41

Vanguard Russell 2000 ETF 0.35

Multi-Manager Small Cap Eq Strat Inst 0.32

TD Health Sciences - I 0.30

Mackenzie GQE US Small Cap F8 0.27

State St Russell Sm Cap® Indx SL Cl I 0.27

Xtrackers MSCI World Swap ETF 1C 0.24

Blackrock Extended Mkt Fund CF 0.23

Alector Inc Market Status

Strong Buy: 5

Buy: 1

Hold: 1

Sell: 1

Strong Sell: 1

Alector Inc Fundamentals

Market Cap 226.24 M

PB Ratio 7.3818

PE Ratio 0.0

Enterprise Value 6.45 M

Total Assets 293.24 M

Volume 1924568

Alector Inc Company Financials

Annual Revenue FY25:21045000 21.0M, FY24:100558000 100.6M, FY23:96312000 96.3M, FY22:133617000 133.6M, FY21:207085000 207.1M

Annual Profit FY25:null 0.0M, FY24:100558000 100.6M, FY23:null 0.0M, FY22:133617000 133.6M, FY21:207085000 207.1M

Annual Net worth FY25:-142929000 -142.9M, FY24:-119049000 -119.0M, FY23:-141385000 -141.4M, FY22:-133310000 -133.3M, FY21:-28014000 -28.0M

Quarterly Revenue Q3/2025:3260000 3.3M, Q2/2025:7874000 7.9M, Q1/2025:3674000 3.7M, Q3/2024:15342000 15.3M, Q2/2024:15083000 15.1M

Quarterly Profit Q3/2025:3260000 3.3M, Q2/2025:7874000 7.9M, Q1/2025:3674000 3.7M, Q3/2024:15342000 15.3M, Q2/2024:12802000 12.8M

Quarterly Net worth Q3/2025:-34667000 -34.7M, Q2/2025:-30524000 -30.5M, Q1/2025:-40471000 -40.5M, Q3/2024:-42220000 -42.2M, Q2/2024:-38676000 -38.7M

About Alector Inc & investment objective

Company Information Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson's disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer's disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson's disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.

Organisation Biotechnology

Employees 103

Industry Biotechnology

CEO Dr. Arnon Rosenthal Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Alector Inc FAQs

What is the share price of Alector Inc today?

The current share price of Alector Inc is $2.05.

Can I buy Alector Inc shares in India?

Yes, Indian investors can buy Alector Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Alector Inc shares in India?

You can easily invest in Alector Inc shares from India by:

Can I buy fractional shares of Alector Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Alector Inc?

Alector Inc has a market cap of $226.24 M.

In which sector does Alector Inc belong?

Alector Inc operates in the Biotechnology sector.

What documents are required to invest in Alector Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Alector Inc?

The PE ratio of Alector Inc is N/A and the PB ratio is 7.38.